true
Icon to close the modal
Sûúppóòrt
Sæãléës
Phöõnêê Îcöõn
1.844.8.BD.LIFE (1.844.823.5433)
Móõdãäl Clóõsëé Ìcóõn

Cæâpæâbìílìíty:

Pròòdûùct Lïínéé:

Îcóón tóó clóósèê thæànk yóóùú móódæàl
Thâãnk yõóüú fõór cõóntâãctïìng õóüúr sâãlëés tëéâãm!
Ä sáälëès rëèprëèsëèntíìvëè wíìll gëèt íìn töòýûch wíìth yöòýû shöòrtly.
Cûûstõòmèèr Sèèrvîïcèè
Phöõnêê Îcöõn
1.844.8.BD.LIFE (1.844.823.5433)
Fäáx Îcõón
1.800.847.2220

Dispositif de fixation résorbable Sorbafix™

Attaches résorbables en PDLLA disponibles en configurations de 15 et 30 unités livrées avec un applicateur de 5 mm à usage unique.

Nous contacter
SorbaFix
Loading
Présentation

Smart Design. Not Sharp Design.

The unique fastener design of the SorbaFix™ Absorbable Fixation system means no sharp points are left behind in the patient. Preclinical data shows that a hollow core allows tissue in-growth through the fastener.2 The 5 mm depth of tissue purchase and consistent thread diameter from head to tip assure maximum tissue engagement during open and laparoscopic procedures. TheSorbaFix™ Absorbable Fixation System has a 5 mm, low-profile delivery system that offers smooth, efficient deployment. Keeping track of the pre-loaded 15- or 30-fastener configurations is now easy with a new fastener gauge.

true
Caractéristiques et avantages

Résistant :

 

    • La résistance de la réparation est environ 7 fois plus élevée que la pression intra-abdominale (PIA). 1, 2
    • Le centre creux et fileté favorise la l’intégration tissulaire à travers l’intérieur de l’attache.2

    Résistant :

     

      L’attache SorbaFix™ conserve 100 % de sa résistance pendant 2 mois, assurant ainsi la sécurité de la fixation pendant la période de cicatrisation initiale.2

      Données précliniques. Il est possible que les résultats ne correspondent pas aux performances chez l’homme.

      Uniforme :

       

        • Le diamètre uniforme des filetages de haut en bas et la longueur de l’attache sont conçus pour maximiser l’engagement du tissu.
        • L’obturateur à pointe de guidage oriente efficacement l’attache à travers la maille et le tissu.

        Fiable :

         

          • Attache à pointe émoussée atraumatique avec tête lisse et sans point exposé.
          • La conception innovante du mécanisme garantit un système de mise en place durable.
          • La résorption des attaches en poly (D, L)-lactide (PDLLA) est quasiment achevée environ 12 mois après l’implantation, permettant de laisser une moindre quantité de matériau étranger dans le corps.2
          Products & Accessories
          RELATED PRODUCTS NOT AVAILABLE
          References

           

          1. Twardowski ZJ et al “Intraabdominal Pressures during Natural Activities in Patients Treated with Continuous Ambulatory Peritoneal Dialysis” Nephron 44:129-135 1986. Cobb WS et al. "The Argument for Lightweight Polypropylene Mesh in Hernia Repair" Surgical Innovation. Vol 12 (1).63-69, 2005.

          2. Data generated from an animal study using the SORBAFIX™ Absorbable Fixation System and from a cadaver study using the PERMAFIX™ Permanent Fixation System. Data on file. Results may not correlate to performance in humans.

          Indications

          The SorbaFix™ Absorbable Fixation System is indicated for the approximation of soft tissue and fixation of surgical mesh to tissues during laparoscopic surgical procedures, such as hernia repair.

           Contraindications

          1. This device is not intended for use except as indicated.

          2. Do not use this device where hemostasis cannot be verified visually after application.

          3. Contraindications associated with laparoscopic surgical procedures relative to mesh fixation apply, including but not limited to: • Fixation of vascular or neural structures • Fixation of bone and cartilage • Situations with insufficient in-growth of tissue into the mesh over time, which could result in inadequate fixation once the fastener is resorbed.

          4. Carefully inspect the area in the vicinity of the tissue being fastened to avoid inadvertent penetration of underlying structures such as nerves, vessels, viscera, or bone. Use of the SorbaFix™ Absorbable Fixation System in the close vicinity of such underlying structures is contraindicated. For reference, the length of the fastener is 6.0 mm, the fastener head is another 0.7 mm (total 6.7 mm).

           Warnings

          1. The SorbaFix™ Absorbable Fixation System is intended for Single Use Only – DO NOT RESTERILIZE. Reuse, reprocessing, re-sterilization, or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the device and may lead to device failure which may result in injury to the patient. Reuse, reprocessing, re-sterilization, or repackaging may also create a risk of contamination of the device and/or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another. Contamination of the device may lead to injury, illness, or death of the patient or end user. This product is supplied sterile. Inspect the packaging to be sure it is intact and undamaged prior to use.

          2. Do not use beyond the expiration date on the package.

          3. Do not use if the center of the temperature indicator is black.

          4. As with any implant material the presence of bacterial contamination may enhance bacterial infectivity. Accepted surgical practices must be followed with respect to drainage and closure of infected or contaminated wounds.

          5. Users should be familiar with surgical procedures and techniques involving synthetic absorbable materials before employing SorbaFix™ Absorbable Fixation System fasteners for wound closure, as the risk of wound dehiscence may vary with the site of application and the material used.

          6. The device may not fixate through prosthetics derived from biologic material such as xenografts and allografts. Prosthetics should be evaluated for compatibility prior to use. To prevent patient injury from the piloting tip, stay clear of vessels, nerves, bowel, and viscera when entering the surgical site, manipulating tissue, and fixating mesh.

          7. To prevent patient injury from the piloting tip, stay clear of vessels, nerves, bowel, and viscera when entering the surgical site, manipulating tissue, and fixating mesh. After use, the SorbaFix™ Absorbable Fixation System may be a potential biohazard. This device has a piloting tip, which should be considered a sharp even when the device is not actuated. Handle and dispose of in accordance with any local and federal laws regarding medical waste and sharps disposal requirements to prevent sharps injuries.

          Precautions

          1. Please read all instructions before using the SorbaFix™ Absorbable Fixation System.

          2. Only persons having adequate medical training and familiarity with surgical techniques should perform surgical procedures. Consult the medical literature relative to technique, complications, and hazards prior to any surgical procedure.

          3. The SorbaFix™ Absorbable Fixation System can be used with most 5 mm trocars. Ensure compatibility by inserting the device into the trocar prior to introduction into the patient. The SorbaFix™ Absorbable Fixation System should enter and exit the trocar easily without excessive force. The use of too much force could damage the instrument.

          4. Counter pressure should be applied on the target area. Avoid placing hand/finger directly over the area where the fastener is being deployed to prevent injury.

          5. Insertion of fasteners into some collagenous structures such as ligaments and tendons is possible but is NOT possible directly into bone or cartilage. This may damage the device.

          6. Avoid excessive trigger force as this may damage the device. 

          7. If the device locks, remove the device from the patient and lightly tap the trigger forward toward the tip to release.

          8. If the device locks and cannot be separated from a fastener that has been deployed into tissue, you may rotate the device counterclockwise to free the device. The locked device should then be discarded, and a new device should be used.

          9. If the fastener does not deploy properly, remove the device from the patient and test the device in air to ensure proper fastener deployment. Once proper fastener deployment is confirmed, the device may be reinserted into the patient.

          10. The safety and effectiveness of SorbaFix™ Absorbable Fixation System have not been evaluated or established in pregnant or breast feeding women.

          11. This device contains the following substance(s) defined as CMR 1B in a concentration above 0.1% weight by weight: Cobalt; CAS No. 7440-48-4; EC No. 231-158-0. Current scientific evidence supports that medical devices manufactured from stainless-steel alloys containing cobalt do not cause an increased risk of cancer or adverse reproductive effects. For more information, please consult the ECHA website: Homepage - ECHA

          Adverse Reaction

          Adverse reactions and potential complications associated with fixation devices such as the SorbaFix™ Absorbable Fixation System may include, but are not limited to the following: hemorrhage; pain, edema, and erythema at wound site; allergic reaction to Poly (D, L)-lactide; septicemia/infection; hernia recurrence/wound dehiscence. Please consult package insert for more detailed safety information and instructions for use.

          true

          Références

           

          1. Twardowski ZJ et al “Intraabdominal Pressures during Natural Activities in Patients Treated with Continuous Ambulatory Peritoneal Dialysis” Nephron 44:129-135 1986. Cobb WS et al. "The Argument for Lightweight Polypropylene Mesh in Hernia Repair" Surgical Innovation. Vol 12 (1).63-69, 2005.

          2. Data generated from an animal study using the SORBAFIX™ Absorbable Fixation System and from a cadaver study using the PERMAFIX™ Permanent Fixation System. Data on file. Results may not correlate to performance in humans.

          Indications

          The SorbaFix™ Absorbable Fixation System is indicated for the approximation of soft tissue and fixation of surgical mesh to tissues during laparoscopic surgical procedures, such as hernia repair.

           Contraindications

          1. This device is not intended for use except as indicated.

          2. Do not use this device where hemostasis cannot be verified visually after application.

          3. Contraindications associated with laparoscopic surgical procedures relative to mesh fixation apply, including but not limited to: • Fixation of vascular or neural structures • Fixation of bone and cartilage • Situations with insufficient in-growth of tissue into the mesh over time, which could result in inadequate fixation once the fastener is resorbed.

          4. Carefully inspect the area in the vicinity of the tissue being fastened to avoid inadvertent penetration of underlying structures such as nerves, vessels, viscera, or bone. Use of the SorbaFix™ Absorbable Fixation System in the close vicinity of such underlying structures is contraindicated. For reference, the length of the fastener is 6.0 mm, the fastener head is another 0.7 mm (total 6.7 mm).

           Warnings

          1. The SorbaFix™ Absorbable Fixation System is intended for Single Use Only – DO NOT RESTERILIZE. Reuse, reprocessing, re-sterilization, or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the device and may lead to device failure which may result in injury to the patient. Reuse, reprocessing, re-sterilization, or repackaging may also create a risk of contamination of the device and/or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another. Contamination of the device may lead to injury, illness, or death of the patient or end user. This product is supplied sterile. Inspect the packaging to be sure it is intact and undamaged prior to use.

          2. Do not use beyond the expiration date on the package.

          3. Do not use if the center of the temperature indicator is black.

          4. As with any implant material the presence of bacterial contamination may enhance bacterial infectivity. Accepted surgical practices must be followed with respect to drainage and closure of infected or contaminated wounds.

          5. Users should be familiar with surgical procedures and techniques involving synthetic absorbable materials before employing SorbaFix™ Absorbable Fixation System fasteners for wound closure, as the risk of wound dehiscence may vary with the site of application and the material used.

          6. The device may not fixate through prosthetics derived from biologic material such as xenografts and allografts. Prosthetics should be evaluated for compatibility prior to use. To prevent patient injury from the piloting tip, stay clear of vessels, nerves, bowel, and viscera when entering the surgical site, manipulating tissue, and fixating mesh.

          7. To prevent patient injury from the piloting tip, stay clear of vessels, nerves, bowel, and viscera when entering the surgical site, manipulating tissue, and fixating mesh. After use, the SorbaFix™ Absorbable Fixation System may be a potential biohazard. This device has a piloting tip, which should be considered a sharp even when the device is not actuated. Handle and dispose of in accordance with any local and federal laws regarding medical waste and sharps disposal requirements to prevent sharps injuries.

          Precautions

          1. Please read all instructions before using the SorbaFix™ Absorbable Fixation System.

          2. Only persons having adequate medical training and familiarity with surgical techniques should perform surgical procedures. Consult the medical literature relative to technique, complications, and hazards prior to any surgical procedure.

          3. The SorbaFix™ Absorbable Fixation System can be used with most 5 mm trocars. Ensure compatibility by inserting the device into the trocar prior to introduction into the patient. The SorbaFix™ Absorbable Fixation System should enter and exit the trocar easily without excessive force. The use of too much force could damage the instrument.

          4. Counter pressure should be applied on the target area. Avoid placing hand/finger directly over the area where the fastener is being deployed to prevent injury.

          5. Insertion of fasteners into some collagenous structures such as ligaments and tendons is possible but is NOT possible directly into bone or cartilage. This may damage the device.

          6. Avoid excessive trigger force as this may damage the device. 

          7. If the device locks, remove the device from the patient and lightly tap the trigger forward toward the tip to release.

          8. If the device locks and cannot be separated from a fastener that has been deployed into tissue, you may rotate the device counterclockwise to free the device. The locked device should then be discarded, and a new device should be used.

          9. If the fastener does not deploy properly, remove the device from the patient and test the device in air to ensure proper fastener deployment. Once proper fastener deployment is confirmed, the device may be reinserted into the patient.

          10. The safety and effectiveness of SorbaFix™ Absorbable Fixation System have not been evaluated or established in pregnant or breast feeding women.

          11. This device contains the following substance(s) defined as CMR 1B in a concentration above 0.1% weight by weight: Cobalt; CAS No. 7440-48-4; EC No. 231-158-0. Current scientific evidence supports that medical devices manufactured from stainless-steel alloys containing cobalt do not cause an increased risk of cancer or adverse reproductive effects. For more information, please consult the ECHA website: Homepage - ECHA

          Adverse Reaction

          Adverse reactions and potential complications associated with fixation devices such as the SorbaFix™ Absorbable Fixation System may include, but are not limited to the following: hemorrhage; pain, edema, and erythema at wound site; allergic reaction to Poly (D, L)-lactide; septicemia/infection; hernia recurrence/wound dehiscence. Please consult package insert for more detailed safety information and instructions for use.

          true

          SORBAFIX™ est un système de fixation résorbable SORBAFIX™ est indiqué pour le rapprochement des tissus mous et la fixation d’un filet chirurgical sur des tissus lors d’interventions chirurgicales à ciel ouvert ou laparoscopiques, telles que les cures de hernies. Dispositif médical de classe III (MDR 2017/745), CE 2797 Fabricant: Davol inc. Pour un bon usage se référer à la notice d'utilisation. Edition février 2023

          Références

          1. Twardowski ZJ et al “Intraabdominal Pressures during Natural Activities in Patients Treated with Continuous Ambulatory Peritoneal Dialysis” Nephron 44:129-135 1986. Cobb WS et al. "The Argument for Lightweight Polypropylene Mesh in Hernia Repair" Surgical Innovation. Vol 12 (1).63-69, 2005.
          2. Données issues d’une étude chez l’animal portant sur l’utilisation du système de fixation résorbable SORBAFIX™ et d’une étude cadavérique portant sur l’utilisation du système de fixation permanent PERMAFIX™. Données archivées. Il est possible que les résultats ne correspondent pas aux performances chez l’homme.

          BD-119799

          Dispositif de fixation résorbable Sorbafix™ - BD BD Dispositif de fixation résorbable Sorbafix™

          Résistant :

           

            ,
            • La résistance de la réparation est environ 7 fois plus élevée que la pression intra-abdominale (PIA). 1, 2
            • Le centre creux et fileté favorise la l’intégration tissulaire à travers l’intérieur de l’attache.2
            ,

            Résistant :

             

              ,

              L’attache SorbaFix™ conserve 100 % de sa résistance pendant 2 mois, assurant ainsi la sécurité de la fixation pendant la période de cicatrisation initiale.2

              Données précliniques. Il est possible que les résultats ne correspondent pas aux performances chez l’homme.

              ,

              Uniforme :

               

                ,
                • Le diamètre uniforme des filetages de haut en bas et la longueur de l’attache sont conçus pour maximiser l’engagement du tissu.
                • L’obturateur à pointe de guidage oriente efficacement l’attache à travers la maille et le tissu.
                ,

                Fiable :

                 

                  ,
                  • Attache à pointe émoussée atraumatique avec tête lisse et sans point exposé.
                  • La conception innovante du mécanisme garantit un système de mise en place durable.
                  • La résorption des attaches en poly (D, L)-lactide (PDLLA) est quasiment achevée environ 12 mois après l’implantation, permettant de laisser une moindre quantité de matériau étranger dans le corps.2
                  /content/dam/bd-assets/bd-com/en-us/logos/bd/header-bd-logo.svg

                  Attaches résorbables en PDLLA disponibles en configurations de 15 et 30 unités livrées avec un applicateur de 5 mm à usage unique.

                  sorbafix (10 AMS), système de fixation résorbable sorbafix (N/A)